— Know what they know.
Not Investment Advice
Also trades as: EXEEL (NASDAQ) · $vol 1M · EXEEW (NASDAQ) · $vol 0M · EXEEZ (NASDAQ) · $vol 0M

EXE NASDAQ

Expand Energy Corporation
1W: -1.5% 1M: -13.9% 3M: -3.8% YTD: -22.1% 1Y: -21.3% 3Y: +6.2% 5Y: +80.0%
$85.52
-0.44 (-0.51%)
 
Weekly Expected Move ±3.8%
$79 $82 $86 $89 $92
NASDAQ · Energy · Oil & Gas Exploration & Production · Tech Score Sell · Power 41 · $19.8B mcap · 230M float · 1.52% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
47.6 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 12.6%  ·  5Y Avg: 21.1%
Cost Advantage
28
Intangibles
55
Switching Cost
56
Network Effect
32
Scale ★
63
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. EXE shows a Weak competitive edge (47.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 12.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$93
Low
$123
Avg Target
$147
High
Based on 12 analysts since Jul 28, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 16Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$122.71
Analysts14
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-02 UBS — $129 $122 -7 +41.9% $85.97
2026-10-01 Jefferies — $141 $136 -5 +58.2% $85.96
2026-09-14 UBS Josh Silverstein $124 $129 +5 +36.0% $94.83
2026-09-09 Stifel Nicolaus David Deckelbaum Initiated $135 — +39.7% $96.62
2026-09-09 Raymond James John Freeman Initiated $147 — +49.7% $98.19
2026-08-26 Goldman Sachs — Initiated $113 — +19.4% $94.66
2026-08-19 Morgan Stanley — $131 $129 -2 +33.8% $96.40
2026-08-17 Johnson Rice — Initiated $125 — +33.5% $93.62
2026-08-17 Barclays — $110 $107 -3 +12.9% $94.78
2026-07-30 UBS Josh Silverstein $127 $124 -3 +35.9% $91.24
2026-07-29 Roth Capital — $125 $93 -32 -0.0% $93.03
2026-07-29 Wolfe Research Doug Leggate $146 $114 -32 +24.0% $91.95
2026-07-10 Truist Financial — $133 $117 -16 +34.9% $86.73
2026-07-10 UBS Josh Silverstein $135 $127 -8 +45.8% $87.11
2026-06-29 Morgan Stanley — $139 $131 -8 +48.1% $88.47
2026-05-26 Barclays — $125 $110 -15 +12.3% $97.94
2026-05-22 Morgan Stanley — $141 $139 -2 +43.2% $97.08
2026-04-09 Truist Financial — Initiated $133 — +33.7% $99.50
2026-03-27 Morgan Stanley — $135 $141 +6 +24.2% $113.50
2026-02-23 UBS — $150 $135 -15 +27.3% $106.04
2026-02-23 Wells Fargo — Initiated $123 — +13.8% $108.06
2026-02-23 Barclays Betty Jiang $126 $125 -1 +15.7% $108.06
2026-02-19 Jefferies Lloyd Byrne $143 $141 -2 +41.7% $99.52
2026-02-18 Stephens — $140 $146 +6 +42.1% $102.75
2026-01-28 Piper Sandler — $101 $137 +36 +25.9% $108.82
2026-01-21 Barclays — $136 $126 -10 +14.7% $109.85
2026-01-20 Stephens — $118 $140 +22 +40.2% $99.88
2026-01-08 UBS Josh Silverstein $154 $150 -4 +42.0% $105.61
2026-01-08 Jefferies — $135 $143 +8 +34.1% $106.66
2026-01-05 Bernstein — Initiated $144 — +31.2% $109.77
2025-12-12 UBS — $132 $154 +22 +35.3% $113.82
2025-12-12 Mizuho Securities Nitin Kumar $136 $142 +6 +24.2% $114.31
2025-10-30 UBS — $131 $132 +1 +31.5% $100.41
2025-10-14 Morgan Stanley Devin McDermott $136 $135 -1 +34.6% $100.33
2025-10-13 UBS Josh Silverstein Initiated $131 — +28.7% $101.75
2025-10-09 Scotiabank — Initiated $150 — +40.4% $106.84
2025-10-07 Barclays — $117 $136 +19 +26.2% $107.73
2025-09-15 Mizuho Securities Nitin Kumar $110 $136 +26 +42.3% $95.58
2025-07-30 Roth Capital — $116 $125 +9 +20.0% $104.21
2025-06-14 Jefferies Lloyd Byrne Initiated $135 — +15.9% $116.46
2025-06-13 KeyBanc Tim Rezvan Initiated $135 — +15.9% $116.46
2025-04-15 Stephens Mike Scialla $86 $118 +32 +13.2% $104.23
2025-03-06 Piper Sandler — Initiated $101 — +4.9% $96.24
2025-02-28 Barclays — Initiated $117 — +18.3% $98.88
2025-01-23 Roth Capital Leo Mariani Initiated $116 — +9.4% $106.00
2025-01-22 Morgan Stanley Devin McDermott Initiated $136 — +26.7% $107.35
2025-01-03 Wolfe Research Doug Leggate Initiated $146 — +46.3% $99.78
2024-10-30 Citigroup Paul Diamond Initiated $100 — +12.7% $88.70
2024-10-30 Stephens Mike Scialla $85 $86 +1 +0.3% $85.73
2024-10-30 Mizuho Securities Nitin Kumar $105 $110 +5 +25.9% $87.36

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 02, 2026
DCF
5
ROE
4
ROA
5
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. EXE receives an overall rating of A. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-08-24 A+ A
2026-08-18 A A+
2026-08-17 A+ A
2026-07-29 A A+
2026-06-24 A+ A
2026-04-29 S- A+
2026-04-28 A S-
2026-04-24 A- A
2026-03-05 B+ A-
2026-03-02 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 77 Grade A+
Profitability
69
Balance Sheet
77
Earnings Quality
71
Growth
77
Value
87
Momentum
100
Safety
65
Cash Flow
74
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. EXE scores highest in Momentum (100/100) and lowest in Safety (65/100). An overall grade of A+ places EXE among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.70
Grey Zone
Piotroski F-Score
9/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-7.07
Unlikely Manipulator
Ohlson O-Score
-11.05
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 87.0/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.03x
Accruals: -10.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. EXE scores 2.70, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. EXE scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. EXE's score of -7.07 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. EXE's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. EXE receives an estimated rating of AA (score: 87.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). EXE's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
7.32x
PEG
0.00x
P/S
1.48x
P/B
1.05x
P/FCF
8.55x
P/OCF
3.85x
EV/EBITDA
3.63x
EV/Revenue
1.80x
EV/EBIT
6.52x
EV/FCF
9.48x
Earnings Yield
12.79%
FCF Yield
11.70%
Shareholder Yield
6.19%
Graham Number
$146.21
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 7.3x earnings, EXE trades at a deep value multiple. An earnings yield of 12.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $146.21 per share, suggesting a potential 71% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.787
NI / EBT
×
Interest Burden
0.956
EBT / EBIT
×
EBIT Margin
0.277
EBIT / Rev
×
Asset Turnover
0.479
Rev / Assets
×
Equity Multiplier
1.494
Assets / Equity
=
ROE
14.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. EXE's ROE of 14.9% is driven by Asset Turnover (0.479), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$449.19
Price/Value
0.20x
Margin of Safety
79.70%
Premium
-79.70%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with EXE's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $449.19, EXE appears undervalued with a 80% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 7.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1417 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$85.52
Median 1Y
$94.87
5th Pctile
$51.51
95th Pctile
$174.80
Ann. Volatility
34.4%
Analyst Target
$122.71
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,600
-5.9% YoY
Revenue / Employee
$7,280,000
Rev: $11,648,000,000
Profit / Employee
$1,136,875
NI: $1,819,000,000
SGA / Employee
$2,088,125
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 1.6% 1.1% -2.5% 33.9% 59.5% 66.7% 90.5% 77.1% 65.4% 24.4% 10.1% 4.2% 2.5% -5.0% -7.1% 1.5% 6.1% 10.1% 17.6% 14.9% 14.89%
ROA 66.8% 57.5% -1.1% 14.9% 26.1% 37.3% 50.8% 44.1% 38.3% 16.2% 7.4% 3.1% 1.8% -3.4% -4.7% 1.0% 4.2% 6.5% 11.2% 10.0% 9.97%
ROIC -10.8% 33.4% 11.0% 33.1% 46.3% 41.9% 59.0% 54.9% 47.3% 20.7% 9.1% 3.8% 2.2% -2.7% -3.9% 1.3% 4.4% 8.0% 14.4% 12.6% 12.56%
ROCE 1.0% 73.7% -1.3% 17.1% 30.5% 29.9% 50.6% 44.0% 37.2% 24.7% 11.2% 5.0% 3.2% -2.9% -4.2% 2.2% 5.7% 9.9% 16.9% 14.8% 14.75%
Gross Margin -34.5% 63.4% -1.6% 39.2% 73.2% 55.7% 74.1% 6.8% 57.2% 65.1% 41.2% -37.6% 16.9% 31.9% 35.3% 38.3% 79.5% 46.4% 53.2% 78.6% 78.58%
Operating Margin -38.1% 63.3% -1.2% 38.3% 31.8% 54.0% 60.0% 36.4% 5.2% 40.1% 3.0% -58.4% -24.0% -19.3% -12.2% 34.4% 24.4% 18.3% 34.8% 22.3% 22.33%
Net Margin -38.9% 33.7% -1.2% 35.4% 27.9% 86.8% 45.8% 27.6% 4.6% 31.5% 2.4% -45.1% -17.6% -20.0% -11.3% 26.3% 18.4% 18.1% 26.4% 17.6% 17.64%
EBITDA Margin -38.1% 52.2% -56.1% 51.5% 45.8% 65.1% 73.2% 64.8% 31.6% 62.9% 42.2% 15.1% 31.0% 14.5% 20.5% 55.8% 50.0% 49.4% 51.4% 46.7% 46.72%
FCF Margin 24.8% 14.4% 20.3% 16.8% 17.9% 20.1% 15.8% 14.3% 9.8% 7.1% 5.0% 4.3% 6.2% 0.1% 7.6% 13.7% 13.6% 14.3% 20.3% 19.0% 19.01%
OCF Margin 40.2% 24.5% 34.7% 29.8% 31.4% 36.0% 30.1% 32.1% 29.3% 30.6% 35.1% 35.5% 40.9% 37.0% 39.4% 37.7% 36.9% 38.4% 41.6% 42.2% 42.21%
ROE 3Y Avg snapshot only 6.57%
ROE 5Y Avg snapshot only 21.33%
ROA 3Y Avg snapshot only 4.63%
ROIC 3Y Avg snapshot only 5.55%
ROIC Economic snapshot only 11.95%
Cash ROA snapshot only 20.14%
Cash ROIC snapshot only 25.92%
CROIC snapshot only 11.68%
NOPAT Margin snapshot only 20.45%
Pretax Margin snapshot only 26.43%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 17.87%
SBC / Revenue snapshot only 0.25%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 1.00 0.98 -76.99 6.66 4.28 2.54 1.43 1.79 2.13 4.26 11.38 23.67 42.00 -31.48 -25.73 133.84 29.34 14.58 8.19 7.82 7.322
P/S Ratio 1.61 0.85 1.35 1.12 1.03 1.09 0.73 0.95 1.14 1.33 2.07 2.12 2.65 5.32 4.76 3.23 2.34 2.23 1.88 1.63 1.481
P/B Ratio 1.61 1.10 1.63 1.79 1.88 1.37 0.99 1.08 1.12 0.96 1.12 1.00 1.05 1.28 1.48 1.54 1.40 1.43 1.35 1.12 1.050
P/FCF 6.50 5.90 6.66 6.64 5.76 5.44 4.64 6.68 11.71 18.72 41.43 48.90 42.84 5618.87 62.68 23.69 17.30 15.58 9.23 8.55 8.551
P/OCF 4.01 3.48 3.90 3.76 3.28 3.03 2.43 2.97 3.90 4.33 5.88 5.97 6.47 14.40 12.09 8.57 6.36 5.81 4.50 3.85 3.851
EV/EBITDA 1.05 1.04 10.55 4.06 2.85 2.80 1.49 1.71 2.05 2.39 4.33 5.33 6.25 27.49 29.93 10.65 6.93 5.57 4.01 3.63 3.634
EV/Revenue 1.75 1.04 1.78 1.45 1.26 1.36 0.88 1.06 1.28 1.46 2.22 2.33 2.90 6.63 5.69 3.74 2.73 2.57 2.08 1.80 1.802
EV/EBIT 1.09 1.21 -100.44 8.13 4.85 4.09 1.89 2.21 2.75 3.52 8.90 17.95 28.82 -39.36 -29.67 59.64 20.99 12.17 6.77 6.52 6.516
EV/FCF 7.04 7.24 8.77 8.59 7.02 6.78 5.55 7.41 13.13 20.62 44.55 53.86 46.87 6995.87 74.91 27.41 20.18 17.99 10.22 9.48 9.480
Earnings Yield 99.8% 1.0% -1.3% 15.0% 23.3% 39.4% 70.0% 55.7% 47.0% 23.5% 8.8% 4.2% 2.4% -3.2% -3.9% 0.7% 3.4% 6.9% 12.2% 12.8% 12.79%
FCF Yield 15.4% 16.9% 15.0% 15.1% 17.4% 18.4% 21.6% 15.0% 8.5% 5.3% 2.4% 2.0% 2.3% 0.0% 1.6% 4.2% 5.8% 6.4% 10.8% 11.7% 11.70%
PEG Ratio snapshot only 0.003
Price/Tangible Book snapshot only 1.120
EV/OCF snapshot only 4.270
EV/Gross Profit snapshot only 2.856
Acquirers Multiple snapshot only 6.937
Shareholder Yield snapshot only 6.19%
Graham Number snapshot only $146.21
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.69 0.86 0.34 0.47 0.49 1.00 1.39 1.34 1.56 1.99 2.33 2.16 2.00 0.64 0.59 0.78 0.81 1.01 1.11 0.96 0.959
Quick Ratio 0.69 0.86 0.34 0.47 0.49 1.00 1.39 1.34 1.56 1.99 2.33 2.16 2.00 0.64 0.59 0.78 0.81 1.01 1.11 0.96 0.959
Debt/Equity 0.42 0.41 0.52 0.53 0.43 0.35 0.21 0.20 0.21 0.20 0.20 0.20 0.20 0.33 0.31 0.29 0.28 0.27 0.26 0.19 0.192
Net Debt/Equity 0.14 0.25 0.52 0.53 0.41 0.34 0.19 0.12 0.14 0.10 0.08 0.10 0.10 0.31 0.29 0.24 0.23 0.22 0.15 0.12 0.122
Debt/Assets 0.17 0.21 0.21 0.22 0.20 0.21 0.15 0.15 0.15 0.15 0.15 0.15 0.15 0.21 0.19 0.19 0.18 0.18 0.17 0.13 0.133
Debt/EBITDA 0.25 0.32 2.56 0.93 0.54 0.58 0.26 0.29 0.33 0.45 0.70 0.97 1.10 5.72 5.23 1.73 1.19 0.92 0.69 0.56 0.562
Net Debt/EBITDA 0.08 0.19 2.53 0.92 0.51 0.55 0.24 0.17 0.22 0.22 0.30 0.49 0.54 5.41 4.89 1.45 0.99 0.75 0.39 0.36 0.356
Interest Coverage 84.22 75.07 -1.24 14.92 20.58 23.84 38.93 37.19 38.54 31.05 16.87 7.57 5.00 -5.78 -6.29 2.64 5.89 10.71 18.40 16.96 16.963
Equity Multiplier 2.41 1.94 2.47 2.39 2.22 1.70 1.42 1.39 1.39 1.34 1.31 1.31 1.31 1.59 1.62 1.55 1.52 1.52 1.51 1.44 1.444
Cash Ratio snapshot only 0.461
Debt Service Coverage snapshot only 30.417
Cash to Debt snapshot only 0.366
FCF to Debt snapshot only 0.682
Defensive Interval snapshot only 181.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.42 0.66 0.64 0.89 1.08 0.86 0.99 0.83 0.71 0.52 0.41 0.35 0.29 0.20 0.25 0.41 0.53 0.42 0.49 0.48 0.479
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 3.93 6.78 6.64 7.62 9.20 9.19 12.94 9.60 8.33 7.78 10.13 9.80 8.63 4.71 6.49 12.30 17.45 8.53 12.30 12.50 12.495
Payables Turnover 12.93 15.85 15.32 18.86 15.60 14.22 11.12 9.06 8.49 6.59 6.82 5.68 6.20 5.36 8.26 10.96 10.35 7.76 8.56 5.84 5.839
DSO 93 54 55 48 40 40 28 38 44 47 36 37 42 78 56 30 21 43 30 29 29.2 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 28 23 24 19 23 26 33 40 43 55 54 64 59 68 44 33 35 47 43 63 62.5 days
Cash Conversion Cycle 65 31 31 29 16 14 -5 -2 1 -8 -17 -27 -17 9 12 -4 -14 -4 -13 -33 -33.3 days
Fixed Asset Turnover snapshot only 0.547
Cash Velocity snapshot only 9.788
Capital Intensity snapshot only 2.096
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — 3.4% 3.3% 2.8% 56.7% 1.1% 26.3% -12.8% -32.1% -57.9% -58.3% -60.0% -45.7% -8.1% 74.1% 1.7% 1.8% 1.6% 56.8% 56.80%
Net Income — — -1.0% -70.2% -43.0% -22.0% 63.2% 3.0% 94.6% -51.0% -85.1% -93.0% -95.3% -1.3% -1.9% -53.0% 2.4% 3.5% 4.3% 12.5% 12.50%
EPS — — -1.0% -80.5% -61.2% -37.1% 52.9% 3.2% 97.4% -49.3% -84.8% -92.3% -95.0% -1.2% -1.6% -74.4% 89.8% 3.5% 4.2% 12.6% 12.62%
FCF — — 4.4% 2.2% 1.7% 1.2% 65.9% 7.0% -52.5% -76.1% -86.7% -87.4% -74.7% -99.3% 40.0% 4.5% 4.9% 424.5% 6.1% 1.2% 1.18%
EBITDA — — -81.2% -38.8% 0.5% -23.8% 6.4% 1.2% 23.5% -14.6% -63.4% -70.5% -70.4% -78.6% -66.0% 39.8% 1.3% 4.4% 6.2% 1.2% 1.21%
Op. Income — — 1.8% 97.7% 12.5% 62.6% 4.7% 91.9% 9.4% -16.9% -78.8% -90.3% -93.3% -1.3% -1.8% -15.3% 3.3% 3.8% 4.7% 6.6% 6.55%
OCF Growth snapshot only 75.39%
Asset Growth snapshot only 0.94%
Equity Growth snapshot only 8.21%
Debt Growth snapshot only -28.16%
Shares Change snapshot only -0.92%
Dividend Growth snapshot only 57.24%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — 58.2% 31.4% 9.8% -16.7% -6.3% -2.8% -2.1% 1.3% 0.7% 4.4% 4.42%
Revenue 5Y — — — — — — — — — — — — — — — — — — 57.2% 44.0% 44.02%
EPS 3Y — — — — — — — — — — -49.5% -60.3% -66.4% — — -56.6% -42.9% -39.2% -35.1% -35.5% -35.55%
EPS 5Y — — — — — — — — — — — — — — — — — — -25.4% -26.3% -26.26%
Net Income 3Y — — — — — — — — — — -42.9% -56.3% -62.7% — — -49.1% -32.3% -28.3% -23.1% -23.6% -23.63%
Net Income 5Y — — — — — — — — — — — — — — — — — — -10.7% -11.9% -11.90%
EBITDA 3Y — — — — — — — — — — -20.0% -26.6% -28.4% -48.1% -2.5% -3.3% -5.7% -0.4% -3.6% -3.0% -3.04%
EBITDA 5Y — — — — — — — — — — — — — — — — — — 4.6% 4.1% 4.13%
Gross Profit 3Y — — — — — — — — — — 82.3% 3.4% — -25.5% 11.0% 2.2% -1.2% 6.3% -3.0% 6.6% 6.63%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — 77.6% 2.2% 2.15%
Op. Income 3Y — — — — — — — — — — 50.1% — — — — -45.9% -31.9% -15.5% -13.9% -14.6% -14.56%
Op. Income 5Y — — — — — — — — — — — — — — — — — — 59.1% — —
FCF 3Y — — — — — — — — — — 5.8% -24.4% -30.9% -84.4% -32.4% -9.4% -10.8% -9.6% 9.4% 14.9% 14.89%
FCF 5Y — — — — — — — — — — — — — — — — — — 63.5% 39.0% 38.99%
OCF 3Y — — — — — — — — — — 74.0% 30.5% 10.4% -4.4% -2.2% 5.1% 3.2% 3.4% 12.2% 14.4% 14.43%
OCF 5Y — — — — — — — — — — — — — — — — — — 72.2% 48.5% 48.48%
Assets 3Y — — — — — — — — — — 26.6% 24.8% 22.3% 36.3% 28.1% 25.9% 25.1% 22.3% 26.5% 24.8% 24.78%
Assets 5Y — — — — — — — — — — — — — — — — — — 33.7% 32.0% 31.98%
Equity 3Y — — — — — — — — — — 40.1% 44.8% 49.7% 45.8% 47.3% 45.6% 41.9% 26.7% 23.9% 23.1% 23.14%
Book Value 3Y — — — — — — — — — — 23.9% 31.4% 35.0% 16.4% 18.1% 24.3% 19.7% 7.4% 4.5% 3.9% 3.92%
Dividend 3Y — — — — — — — — — — -38.9% -38.2% -33.9% -26.0% -15.7% -2.4% 11.6% 6.3% 0.5% -2.2% -2.16%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — 0.99 0.93 0.60 0.01 0.26 0.10 0.00 0.32 0.14 0.17 0.09 0.01 0.30 0.49 0.494
Earnings Stability — — — — — — 0.03 0.04 0.04 0.97 0.06 0.20 0.38 0.97 0.28 0.40 0.52 0.71 0.12 0.22 0.222
Margin Stability — — — — — — 0.34 0.03 0.00 0.74 0.48 0.27 0.12 0.64 0.45 0.69 0.86 0.67 0.64 0.39 0.392
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — — — — 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.50 0.50 0.20 0.20 0.50 0.500
Earnings Smoothness — — — 0.00 0.45 0.75 — 0.00 0.36 0.32 0.00 0.00 0.00 — — 0.28 0.00 — — 0.00 0.000
ROE Trend — — — — — — -0.03 -0.30 -0.50 -0.60 -0.24 -0.39 -0.46 -0.42 -0.45 -0.31 -0.23 0.01 0.14 0.12 0.116
Gross Margin Trend — — — — — — 0.38 0.44 0.36 0.18 0.07 0.02 -0.12 -0.26 -0.27 -0.19 0.01 0.10 0.19 0.22 0.225
FCF Margin Trend — — — — — — -0.03 -0.06 -0.12 -0.10 -0.13 -0.11 -0.08 -0.14 -0.03 0.04 0.06 0.11 0.14 0.10 0.100
Sustainable Growth Rate 1.6% 1.1% — 21.0% 41.6% 50.3% 75.5% 64.2% 55.3% 19.5% 6.4% 1.1% -0.7% — — -2.0% 0.7% 5.8% 13.4% 10.8% 10.80%
Internal Growth Rate 1.9% 1.3% — 10.2% 22.3% 39.1% 73.6% 58.1% 48.0% 14.9% 4.9% 0.8% — — — — 0.5% 3.9% 9.4% 7.8% 7.79%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.25 0.28 -19.76 1.77 1.30 0.84 0.59 0.60 0.55 0.98 1.93 3.97 6.49 -2.19 -2.13 15.62 4.61 2.51 1.82 2.03 2.029
FCF/OCF 0.62 0.59 0.58 0.57 0.57 0.56 0.53 0.44 0.33 0.23 0.14 0.12 0.15 0.00 0.19 0.36 0.37 0.37 0.49 0.45 0.450
FCF/Net Income snapshot only 0.914
OCF/EBITDA snapshot only 0.851
CapEx/Revenue 15.4% 10.1% 14.4% 12.9% 13.5% 15.9% 14.3% 17.8% 19.6% 23.5% 30.2% 31.1% 34.7% 36.9% 31.8% 24.1% 23.3% 24.1% 21.3% 23.2% 23.20%
CapEx/Depreciation snapshot only 1.058
Accruals Ratio 0.50 0.41 -0.23 -0.12 -0.08 0.06 0.21 0.17 0.17 0.00 -0.07 -0.09 -0.10 -0.11 -0.15 -0.15 -0.15 -0.10 -0.09 -0.10 -0.103
Sloan Accruals snapshot only -0.086
Cash Flow Adequacy snapshot only 1.460
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.4% 1.9% 3.7% 5.7% 7.0% 9.7% 11.6% 9.3% 7.2% 4.7% 3.2% 3.2% 3.1% 1.7% 1.8% 1.8% 3.0% 2.9% 2.9% 3.5% 2.69%
Dividend/Share $0.68 $1.01 $2.72 $3.97 $5.82 $8.28 $8.13 $7.25 $5.87 $3.44 $2.74 $2.50 $2.46 $1.68 $1.93 $2.04 $3.17 $3.18 $3.17 $3.21 $2.30
Payout Ratio 1.4% 1.9% — 38.0% 30.1% 24.6% 16.6% 16.6% 15.4% 20.1% 36.8% 74.9% 1.3% — — 2.4% 87.9% 42.1% 23.7% 27.5% 27.51%
FCF Payout Ratio 8.9% 11.3% 25.0% 37.9% 40.5% 52.6% 53.9% 62.0% 84.8% 88.4% 1.3% 1.5% 1.3% 97.0% 1.1% 42.2% 51.8% 44.9% 26.7% 30.1% 30.09%
Total Payout Ratio 1.4% 1.9% — 73.7% 54.0% 46.3% 31.3% 27.8% 28.6% 34.8% 65.3% 1.1% 1.5% — — 2.9% 99.4% 47.6% 28.8% 48.4% 48.40%
Div. Increase Streak 0 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0
Chowder Number — — — 16.50 11.61 9.28 2.69 0.84 0.07 -0.55 -0.64 -0.65 -0.58 -0.19 0.18 0.51 1.35 1.00 0.72 0.59 0.593
Buyback Yield 0.0% 0.0% 0.9% 5.4% 5.6% 8.6% 10.3% 6.2% 6.2% 3.4% 2.5% 1.7% 0.4% 0.0% 0.0% 0.4% 0.4% 0.4% 0.6% 2.7% 2.67%
Net Buyback Yield -12.3% -9.7% -12.8% 5.3% 5.6% 8.4% 10.0% 6.0% 6.0% 3.4% 2.5% 1.7% 0.4% 0.0% -0.1% 0.3% 0.3% 0.3% 0.6% 2.6% 2.59%
Total Shareholder Return -10.9% -7.8% -9.0% 11.0% 12.6% 18.0% 21.7% 15.3% 13.3% 8.2% 5.7% 4.8% 3.5% 1.7% 1.7% 2.1% 3.3% 3.2% 3.5% 6.1% 6.11%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.01 1.02 0.55 1.01 0.98 1.35 1.13 1.14 1.19 0.78 0.78 0.81 0.81 0.85 0.83 0.62 0.74 0.80 0.79 0.79 0.787
Interest Burden (EBT/EBIT) 0.99 0.99 1.82 0.93 0.95 0.96 0.97 0.97 0.97 0.97 0.94 0.86 0.78 1.18 1.16 0.62 0.83 0.91 0.95 0.96 0.956
EBIT Margin 1.60 0.86 -0.02 0.18 0.26 0.33 0.46 0.48 0.47 0.42 0.25 0.13 0.10 -0.17 -0.19 0.06 0.13 0.21 0.31 0.28 0.277
Asset Turnover 0.42 0.66 0.64 0.89 1.08 0.86 0.99 0.83 0.71 0.52 0.41 0.35 0.29 0.20 0.25 0.41 0.53 0.42 0.49 0.48 0.479
Equity Multiplier 2.41 1.94 2.18 2.27 2.28 1.79 1.78 1.75 1.71 1.50 1.36 1.35 1.35 1.49 1.51 1.46 1.45 1.55 1.56 1.49 1.494
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $49.83 $53.66 $-0.94 $10.45 $19.32 $33.73 $48.98 $43.58 $38.15 $17.10 $7.45 $3.34 $1.90 $-3.08 $-4.22 $0.86 $3.60 $7.57 $13.40 $11.67 $11.67
Book Value/Share $30.93 $48.09 $44.56 $38.84 $43.96 $62.35 $71.05 $72.56 $72.13 $75.83 $75.36 $79.06 $76.15 $75.86 $73.33 $74.56 $75.45 $77.31 $81.18 $81.43 $81.48
Tangible Book/Share $30.93 $48.09 $44.56 $38.84 $43.96 $62.67 $71.05 $72.56 $72.13 $75.83 $75.36 $79.06 $76.15 $75.86 $73.33 $74.56 $75.45 $77.31 $81.18 $81.43 $81.43
Revenue/Share $31.00 $61.92 $53.72 $62.18 $80.16 $78.19 $95.50 $81.96 $70.88 $54.95 $41.01 $37.33 $30.13 $18.23 $22.80 $35.45 $45.09 $49.50 $58.55 $56.09 $56.12
FCF/Share $7.69 $8.93 $10.90 $10.47 $14.36 $15.73 $15.10 $11.70 $6.93 $3.89 $2.05 $1.62 $1.86 $0.02 $1.73 $4.84 $6.11 $7.08 $11.90 $10.66 $10.67
OCF/Share $12.47 $15.16 $18.65 $18.51 $25.20 $28.19 $28.75 $26.29 $20.79 $16.82 $14.41 $13.24 $12.32 $6.74 $8.98 $13.38 $16.63 $18.99 $24.38 $23.68 $23.69
Cash/Share $8.74 $7.67 $0.24 $0.19 $0.93 $0.89 $0.90 $6.30 $5.01 $7.63 $8.32 $7.77 $7.80 $1.37 $1.49 $3.54 $3.53 $3.99 $9.22 $5.73 $5.73
EBITDA/Share $51.71 $61.92 $9.06 $22.18 $35.36 $38.04 $56.36 $50.78 $44.28 $33.61 $21.07 $16.35 $13.95 $4.40 $4.33 $12.46 $17.80 $22.87 $30.34 $27.82 $27.82
Debt/Share $12.93 $19.64 $23.20 $20.67 $19.07 $21.95 $14.68 $14.80 $14.80 $15.03 $14.72 $15.77 $15.30 $25.16 $22.67 $21.57 $21.09 $21.06 $21.01 $15.64 $15.64
Net Debt/Share $4.19 $11.97 $22.96 $20.48 $18.14 $21.06 $13.78 $8.50 $9.79 $7.41 $6.40 $8.01 $7.50 $23.79 $21.18 $18.03 $17.56 $17.06 $11.79 $9.91 $9.91
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.701
Altman Z-Prime snapshot only 4.161
Piotroski F-Score 3 3 3 5 5 5 7 7 6 6 5 5 5 2 2 5 6 8 8 9 9
Beneish M-Score — — -1.50 -0.89 -3.49 3.85 4.03 5.10 5.83 -8.24 -3.01 -4.23 -2.27 -1.50 -0.96 1.16 -0.38 -2.84 -2.69 -7.07 -7.073
Ohlson O-Score snapshot only -11.054
ROIC (Greenblatt) snapshot only 15.20%
Net-Net WC snapshot only $-24.24
EVA snapshot only $556584380.31
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA
Credit Score 91.47 88.42 34.65 72.12 80.22 89.74 97.09 97.54 95.85 91.61 91.33 85.71 75.28 24.23 26.40 51.96 64.23 82.46 85.44 86.97 86.972
Credit Grade snapshot only 3
Credit Trend snapshot only 35.010
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 90
Sector Credit Rank snapshot only 87

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms